We included forty-nine (n=49) cases and eighty (n=80) controls. Regarding cases with neurological involvement, the median age was 59 (50-69) years, and 63% of patients were female. We diagnosed 65% of cases during hospital stays, and in-hospital mortality was 14.6%. Microscopic polyangiitis accounted for 36.7% of cases, followed by granulomatosis with polyangiitis (30.6%), undetermined ANCA-associated vasculitis (26.5%), and eosinophilic granulomatosis with polyangiitis (6.1%). The most common neurological manifestations were cranial nerve palsy (30.6%), multiple mononeuropathy (26.5%), and headache (24.4%). When compared to the control group, patients with neurological manifestations presented lower levels of creatinine at onset (0.94 vs. 4.37 mg/dL, p<0.001), renal involvement was less frequent (51 vs. 86%, p<0.001), and a five-factor score (FFS) ≥2 was more frequent (44.9 vs 40.2%). Treatment regimens included glucocorticoids 89.8%, cyclophosphamide 46.9%, azathioprine 26.5%, and rituximab 22%.